What does Virax Biolabs Group Ltd do?

Virax Biolabs Group Ltd is a public company in the In Vitro & In Vivo Diagnostic Substances industry, incorporated in E9. It is registered with the SEC under CIK 0001885827 and trades on NASDAQ under the ticker VRAX.

How many SEC filings has Virax Biolabs Group Ltd made?

Virax Biolabs Group Ltd has filed 134 documents with the SEC since 2021. These include annual reports (10-K), quarterly reports (10-Q), current event notices (8-K), and insider transaction disclosures (Form 4).

Virax Biolabs Group Ltd

VRAX NASDAQ CIK: 0001885827 In Vitro & In Vivo Diagnostic Substances Inc. in E9

View on SEC.gov →

Overview All Filings Annual Quarterly Insiders

Recent Filings

All 134 filings →

Form	Description	Date
3	3	Mar 20, 2026
6-K	6-K	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
3	3	Mar 18, 2026
SCHEDULE 13G	—	Feb 17, 2026
6-K	6-K	Jan 30, 2026
424B3	424B3	Dec 31, 2025
EFFECT	—	Dec 30, 2025

Insider Transactions

View all →

No insider transactions loaded yet.

About This Profile

This page aggregates all publicly available SEC EDGAR data for Virax Biolabs Group Ltd. Financial figures are sourced from XBRL-tagged 10-K annual reports. Insider transactions are sourced from Form 4 filings required within two business days of a transaction.

Key Financials

Financial data not yet loaded.

Details

CIK: 0001885827
Ticker: VRAX
Exchange: NASDAQ
Incorporated: E9
First Filing: 2021
Total Filings: 134

In Vitro & In Vivo Diagnostic Substances rankings →